Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AVITA Medical (RCEL) Short-term Investments (2021 - 2025)

AVITA Medical filings provide 5 years of Short-term Investments readings, the most recent being $7.9 million for Q4 2025.

  • On a quarterly basis, Short-term Investments fell 63.63% to $7.9 million in Q4 2025 year-over-year; TTM through Dec 2025 was $7.9 million, a 63.63% decrease, with the full-year FY2025 number at $7.9 million, down 63.63% from a year prior.
  • Short-term Investments hit $7.9 million in Q4 2025 for AVITA Medical, up from $7.9 million in the prior quarter.
  • In the past five years, Short-term Investments ranged from a high of $66.9 million in Q4 2023 to a low of $3.5 million in Q2 2025.
  • Median Short-term Investments over the past 5 years was $29.7 million (2021), compared with a mean of $33.7 million.
  • Biggest five-year swings in Short-term Investments: skyrocketed 178.13% in 2024 and later plummeted 90.51% in 2025.
  • AVITA Medical's Short-term Investments stood at $29.6 million in 2021, then surged by 106.34% to $61.2 million in 2022, then rose by 9.42% to $66.9 million in 2023, then plummeted by 67.38% to $21.8 million in 2024, then crashed by 63.63% to $7.9 million in 2025.
  • The last three reported values for Short-term Investments were $7.9 million (Q4 2025), $7.9 million (Q3 2025), and $3.5 million (Q2 2025) per Business Quant data.